Event Type
Disclosure
Voluntary
Variant
8-K
, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or inc
Other Events. On December 17, 2025 , the Company issued a press release announcing topline efficacy and safety results from the Phase 2b BiRCh study of brensoca
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by Insmed Incorporated on December 17, 2025. 104 Cover Page In